The GHRP 6 (growth hormone-releasing protein-6) is a synthetic analog of the endogenous opioid drug methylenkephalin. It includes unnatural D-amino acid and belongs to both the growth hormone secretagogue and growth hormone-releasing hormone receptor agonist groups. Although it lacks opioid activity growth hormone secretagogue is a powerful stimulator for growth hormone production. GHS is different from growth hormone-releasing hormone (GHRH) because they activate a completely separate receptor, the growth hormone secretagogue receptor or GHSR, which is commonly known as the growth hormone-releasing peptide (GHR). Ghrelin is the natural endogenous ligand to the GHSR. All ghrelin receptor agonists, including the GHRP 6 peptide, act as synthetic ghrelin imitators.
The blood levels of HGH, IGF-1, and GHRP-6 are very high. It is an attractive candidate to treat growth hormone deficiency (cachexia), obesity, eating disorders, and wasting due to its properties. The results of early studies led to a new era in research that identified synthetic GHRP as a potential cardioprotective candidate. The GHRP-6 candidate for myocardial reperfusion injury prevention has been embraced by many because of its safety profile and preclinical success. Initiatives for clinical development have been initiated due to the existence of clinical interventions that are effective but scattered and infrequent in life-threatening situations.
Scientists have investigated the potential benefits of GHRP 6.
- Regeneration is more efficient overall
- Anti-aging and rejuvenation
- Increases vitality and freshness
- Healthy skin with increased collagen production
- Performance and muscle mass increases
- Reduce excess body fat
- Better sleep
- Reduce your risk of developing heart disease or other cardiovascular diseases
- Immune system enhancement
GHRP 6 Dosage.
The optimal dosage of GHRP 6 has been determined in clinical trials and scientific studies. It is typically 1 microgram per 1 kg of body weight.